Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus

Area of Science:

• Infectious Diseases
• Immunology
• Pulmonology

Background:

• Opportunistic respiratory infections, particularly Streptococcus pneumoniae, Mycobacterium tuberculosis, and Pneumocystis jirovecii, are major causes of mortality in individuals with human immunodeficiency virus (HIV).
• Bacterial respiratory pathogens, excluding M. tuberculosis, are the primary focus, with emphasis on pneumococcus as the leading cause of HIV-related mortality in developed nations.
• HIV-mediated immune suppression compromises pulmonary defenses, potentially exacerbated by smoking, increasing susceptibility to respiratory infections.

Purpose of the Study:

• To review bacterial respiratory pathogens in HIV-infected individuals, focusing on Streptococcus pneumoniae.
• To discuss risk factors, the impact of HIV on pulmonary defenses, and diagnostic approaches.
• To outline current antibiotic therapies and pneumococcal immunization recommendations for HIV-positive populations.

Main Methods:

• Literature review focusing on bacterial and fungal respiratory infections in HIV.
• Analysis of risk factors and the role of HIV-induced immunosuppression.
• Examination of diagnostic criteria, disease severity assessment, and treatment guidelines.

Main Results:

• Streptococcus pneumoniae is the leading cause of mortality from respiratory infections in HIV-infected individuals in developed countries.
• HIV infection significantly impairs pulmonary host defenses, increasing vulnerability to bacterial pathogens.
• Effective antibiotic therapy and strategic pneumococcal immunization are crucial for managing respiratory infections in this population.

Conclusions:

• Bacterial respiratory infections, particularly pneumococcal disease, pose a significant threat to individuals with HIV.
• Understanding risk factors and implementing appropriate diagnostic and therapeutic strategies, including vaccination, are essential for improving outcomes.
• The 'prime-boost' immunization strategy using PCV13 and PPSV23 is recommended for pneumococcal protection in HIV-infected individuals.